(b)(4).Teleflex did not receive the device for investigation; therefore, the reported complaint that the "balloon was not intact" is not able to be confirmed.The root cause of the complaint is undetermined.A device history record (dhr) review was conducted for the lot number with no relevant findings.The device passed all manufacturing specifications prior to release.Teleflex assessed the risk for the reported complaint.There are no new or revised risks.The reported complaint will be monitored for any developing trends.No further action required at this time.Other remarks: re: medwatch report # (b)(4).Teleflex received an mdr from fda (ref: (b)(4)) on 2/20/2019.At the time of receipt, we reviewed the information and conducted a search of our complaint tracking system that showed a match of a similar complaint that was already received, including the same account information with similar event details, which also occurred on the same month date.At that time we linked and attached the mdr from fda to the existing complaint in our system, ref: teleflex # (b)(4).During further evaluation of the complaint details, we recognized the complaint did not correctly match the information reported on the mdr from fda.Once we realized the error, we removed the mdr reference from the complaint (ref: teleflex # (b)(4)) and immediately opened a new complaint to link the mdr to a new complaint (ref: teleflex # (b)(4)).For this reason, we are submitting the initial mdr late.This is considered to be an isolated incident due to human error.(b)(4), post market surveillance manager contacted fda (1-888-info-fda (1-888-463-6332) to explain the situation that occurred.The fda stated that the error should be explained on the late mdr submitted and within the complaint file.
|